NINDS BPN Preclinical Testing and Toxicology Programview on SAM.gov

NINDS Blueprint Neurotherapeutics Network (BPN) extended the ordering period of four (4) existing Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded under the BPN Preclinical Testing and Toxicology Program (PTTP), with the contractors listed below. This action extends the ordering period by one year, from September 13, 2026, through September 12, 2027. This is a no-cost modification; no other changes to the contracts' terms, conditions, scope, or ceiling value are being made. SRI International HHSN271201600006I Southern Research HHSN271201600007I IIT Research Institute (IITRI) 75N95021D00026 University of Illinois Chicago, Toxicology Research Laboratory (TRL) 75N95022D00026 Please refer to the attached justification for additional information.